PNC vs TERN · P/E 14, rev $23.10B vs $6.12B cap
PNC Financial Services Group Inc (PNC) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported PNC revenue for 2025-12-31 was $23.10B. Net income was $7.00B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PNC currently screens at market cap $77.76B and trailing P/E 13.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PNC and TERN stock pages for the full models.
Not investment advice.